Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin-Reference-Cited by-同舟云学术

Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin

Published:2006-03 Issue:3 Volume:194 Page:821-827
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Alkazaleh Fawaz,Chaddha Vandana,Viero Sandra,Malik Aasim,Anastasiades Colleen,Sroka Hana,Chitayat David,Toi Ants,Windrim Rory C.,Kingdom John C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference25 articles.

1. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group;Rankin;Paediatr Perinat Epidemiol,2000

2. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000;Khoshnood;BJOG,2004

3. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death;Waller;N Engl J Med,1991

4. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies;Lepage;Am J Obstet Gynecol,2003

5. Double-positive maternal serum screening results for down syndrome and open neural tube defects: an indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes;Chitayat;Am J Obstet Gynecol,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study;BMC Women's Health;2024-06-04

2. Maternal First-Trimester Alpha-Fetoprotein and Placenta-Mediated Pregnancy Complications;Hypertension;2023-11

3. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies;Journal of Obstetrics and Gynaecology Canada;2023-10

4. Directive clinique no 442 : Retard de croissance intra-utérin : Dépistage, diagnostic et prise en charge en contexte de grossesse monofœtale;Journal of Obstetrics and Gynaecology Canada;2023-10

5. Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes;Prenatal Diagnosis;2023-02-14